Atlas Trials

SHR-A1811 Versus Investigator's Chemotherapy in Recurrent/Metastatic Breast Cancer Clinical Trial

Clinical trial NCT05814354 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05814354
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2023-06-30
Primary completion
2026-03-20
Enrollment
551

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.